18 results
20-F/A
2020 FY
SLN
Silence Therapeutics Plc
29 Apr 21
Annual report (foreign) (amended)
4:26pm
medicinal product but that do not meet the definition of a generic medicinal product, for example, because of differences in raw materials
424B4
SLN
Silence Therapeutics Plc
12 Apr 21
Prospectus supplement with pricing info
11:12am
to a reference medicinal product but that do not meet the definition of a generic medicinal product, for example, because of differences in raw materials … drug product will be produced under cGMP as well.
We source key raw materials from third parties, either directly from suppliers or indirectly through
424B4
SLN
Silence Therapeutics Plc
12 Apr 21
Prospectus supplement with pricing info
11:11am
, because of differences in raw materials or manufacturing processes. For such products, the results of appropriate preclinical or clinical trials … product candidates, if approved. The commercial drug product will be produced under cGMP as well.
We source key raw materials from third parties
POS AM
fckd ods983i2khy
8 Apr 21
Prospectus update (post-effective amendment)
9:31am
POS AM
0dwr8feomac
8 Apr 21
Prospectus update (post-effective amendment)
9:18am
20-F
roumji6 p3z5c
30 Mar 21
Annual report (foreign)
5:22pm
424B7
mpnf55t 9o
15 Mar 21
Prospectus with selling stockholder info
10:07am
F-1/A
yn8da42y2ks c9
11 Mar 21
Registration statement (foreign) (amended)
4:02pm
F-1
odm96
8 Mar 21
Registration statement (foreign)
9:50pm
POS AM
9w0twwdcsjb vh
23 Sep 20
Prospectus update (post-effective amendment)
4:47pm
424B4
t4ah1beblc r8o8
8 Sep 20
Prospectus supplement with pricing info
7:31am
F-1
nwzx22qhq0xki
20 Aug 20
Registration statement (foreign)
4:50pm
F-1
EX-10.6
s1gwc6rbw9o
20 Aug 20
Registration statement (foreign)
4:50pm
DRS/A
hsb 2cfz3t9h2i
31 Jul 20
Draft registration statement (amended)
12:00am
DRS
69iwe
22 Jun 20
Draft registration statement
12:00am
DRS
EX-10
lepjtlmyociy
22 Jun 20
Draft registration statement
12:00am
- Prev
- 1
- Next